Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
Luis M. Seijo1,2, Nir Peled3, Daniel Ajona4,5,6,7, Mattia Boeri8, John K. Field9, Gabriella Sozzi8, Ruben Pio4,5,6,7, Javier J. Zulueta10,11, Avrum Spira12, Pierre P. Massion13, Peter J. Mazzone14, Luis M. Montuenga4,5,6,15
1Clinica Universidad de Navarra, Madrid, Spain
2CIBERES, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid, Spain
3Oncology Division, The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel
4Solid Tumors Program, Centro de Investigación Médica Aplicada, Pamplona, Spain
5Navarra Institute for Health Research, Pamplona, Spain
6CIBERONC (Centro de Investigación Biomédica en Red de Cáncer), Madrid, Spain
7Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain
8Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
9The Roy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom
10Department of Pulmonology, Clinica Universidad de Navarra, Pamplona, Spain
11Visiongate Inc., Phoenix, Arizona
12Boston University School of Medicine, Boston, Massachusetts
13Vanderbilt Ingram Cancer Center, Nashville, Tennessee
14Respiratory Institute, Cleveland Clinic, Cleveland, Ohio
15Department of Pathology, Anatomy, and Physiology, School of Medicine, University of Navarra, Pamplona, Spain
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Journal of Thoracic Oncology
Tập 14
343-357
Thông tin tác giả